Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug Renazorb

March 6, 2023

https://www.globenewswire.com/news-release/2023/03/06/2620935/0/en/Unicycive-Announces-up-to-130-Million-Financing-to-Commercialize-and-Launch-Investigational-New-Drug-Renazorb.html

$30 million financing upfront with up to an additional $100 million tied to satisfaction of milestones

Led by Vivo Capital with participation from RA Capital, BVF Partners, Logos Capital, and supported by existing investors Nantahala Capital Partners and Rosalind Advisors Inc.

Read more at globenewswire.com

Related news for (UNCY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.